The Big Sky AI Forum, hosted by Digital Wealth News, convenes top executives, innovators, and thought leaders for high-impact discussions on AI strategy, governance, and innovation in financial services. This year’s agenda features keynote addresses and presentations from industry pioneers including Brian Allen (AI RegRisk Think Tank), Jeremi Karnell (Envestnet Data Solutions), and Matt Tuttle (Tuttle Capital Management), alongside senior executives from Docupace, VastAdvisor, JUMP.ai, and Mature AI.
Dr. Scheer will join the “AI in Real-World Applications” panel on Wednesday, October 8, alongside Philip Brittan (Bloomfire), Ryan Marsh (BrightAI), and Mike Fingado (Athlete Plus). The discussion will explore how AI is driving tangible transformation across industries — from data-driven decision systems to precision diagnostics and operational efficiency.
“AI’s real power lies in its ability to translate complex data into actionable insight,” said Dr. Scheer. “At Alercell, we are applying this philosophy beyond wealth management — into healthcare, precision oncology, and genomics proving that intelligent systems can accelerate both financial and medical innovation.”
Alercell Inc. is pioneering AI-powered diagnostics through its Deep Leukemic Cloud Platform™ (DLCP) and LENA Code©, a suite of epigenetic and methylation-based tests designed for early, accurate, and affordable cancer detection.
The Big Sky AI Forum offers attendees practical playbooks for advice, operations, investing, compliance, and client experience — all in a uniquely intimate, high-value setting known as “The Last Best Place.” The event also includes networking breakfasts, lunches, and a rooftop cocktail mixer overlooking the Bridger Range.
For additional event details or registration, visit dwealth.news/bigSky.
Media Contact:
Cindy Taylor
Email: cindy@fintegration.net
Website: https://dwealth.news/bigSky
Source: Alercell, Inc.
Follow the full story here: https://przen.com/pr/33594711
